Definitive Healthcare (NASDAQ:DH) Trading 8.3% Higher – Here’s What Happened

Definitive Healthcare Corp. (NASDAQ:DH)’s share price traded up 8.3% during mid-day trading on Tuesday . The company traded as high as $5.15 and last traded at $5.15. 439,427 shares traded hands during mid-day trading, a decline of 42% from the average session volume of 755,208 shares. The stock had previously closed at $4.75.

Wall Street Analyst Weigh In

Several research firms recently commented on DH. Barclays restated an “underweight” rating and issued a $4.00 price target on shares of Definitive Healthcare in a research note on Monday, January 13th. Stephens initiated coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price on the stock. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Stock Up 8.4 %

The firm has a market capitalization of $594.93 million, a price-to-earnings ratio of -1.66, a P/E/G ratio of 3.65 and a beta of 1.44. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The stock has a fifty day moving average of $4.42 and a two-hundred day moving average of $4.43.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.03). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The firm had revenue of $62.70 million for the quarter, compared to analyst estimates of $61.66 million. During the same quarter last year, the company earned $0.01 earnings per share. Sell-side analysts anticipate that Definitive Healthcare Corp. will post 0.15 earnings per share for the current year.

Insider Buying and Selling

In related news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 14.84% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Definitive Healthcare

Institutional investors have recently modified their holdings of the company. Millennium Management LLC purchased a new stake in shares of Definitive Healthcare in the second quarter valued at about $9,283,000. Massachusetts Financial Services Co. MA increased its stake in Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after buying an additional 1,626,813 shares during the last quarter. 272 Capital LP lifted its position in shares of Definitive Healthcare by 74.8% during the 3rd quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after buying an additional 476,766 shares in the last quarter. State Street Corp boosted its stake in shares of Definitive Healthcare by 29.4% in the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after buying an additional 317,952 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Definitive Healthcare by 431.7% in the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after acquiring an additional 180,323 shares in the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.